In a follow-up study of 349 patients with diabetic kidney disease, followed for 5–18 years, baseline tumor necrosis factor receptor 2 was associated with an increased risk of end-stage renal disease (83). The gene discussed is TNFRSF1B; the disease is stage 5 chronic kidney disease.